Inovio Pharmaceuticals, Inc. (INO) vs MediciNova, Inc. (MNOV)
A side-by-side comparison of Inovio Pharmaceuticals, Inc. and MediciNova, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INO
Inovio Pharmaceuticals, Inc.
$1.13HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
MNOV
MediciNova, Inc.
$1.69HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — INO vs MNOV
growth of $100 · dividends reinvested · last 10yINO -99.0% (-36.7%/yr)MNOV -75.0% (-12.9%/yr)MNOV compounded faster over this window
Log scale — wide-divergence pair
INO MNOV
INO vs MNOV: by the numbers
- •MNOV is the larger company ($83M vs $78M market cap).
- •Both run net losses; MNOV's is the smaller (-1168.20% vs -130000.00% net margin).
Metrics side by side
Valuation
| Metric | INO | MNOV |
|---|---|---|
| P/S ratio | N/A | 90.37 |
| P/B ratio | 17.86 | 2.23 |
Profitability
| Metric | INO | MNOV |
|---|---|---|
| Gross margin | 100.00% | 7.58% |
| Operating margin | -132871.32% | -3242.47% |
| Net margin | -130000.00% | -1168.20% |
| ROE | -1542.57% | -28.85% |
| ROIC | -836.58% | -31.62% |
Growth (annualized)
| Metric | INO | MNOV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -25.46% |
| Total return CAGR (5Y) | -57.05% | -13.62% |
Frequently asked
- How have INO and MNOV total returns compared?
- Over the past 10 years, INO delivered -36.78% and MNOV delivered -13.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.